Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

TCT-41 A Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin-Strut Sirolimus-Eluting Coronary Stent Supraflex: 2-Year Results of the TALENT Trial

2019; Elsevier BV; Volume: 74; Issue: 13 Linguagem: Inglês

10.1016/j.jacc.2019.08.071

ISSN

1558-3597

Autores

Patrick W. Serruys, Azfar Zaman, Robert de Winter, Norihiro Kogame, Rodrigo Modolo, Pim A.L. Tonino, Sjoerd H. Hofma, Pieter C. Smits, Janusz Prokopczuk, Raúl Moreno, Anirban Choudhury, Ivo Petrov, Ángel Cequier, Neville Kukreja, Imre Ungi, Antonio Serra, Robert Gil, Simon Walsh, Anthony Mathur, Béla Merkely, Antonio Colombo, Alexander Ijsselmuiden, Osama Soliman, Yoshinobu Onuma,

Tópico(s)

Coronary Interventions and Diagnostics

Resumo

Supraflex is a sirolimus-eluting stent with a biodegradable polymeric coating and ultra-thin struts. We sought to compare it with the standard of care, Xience, an everolimus-eluting stent with a durable coating, with respect to clinical outcomes in a randomized trial in an all-comers population.

Referência(s)